Dean Lim

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

Alexa B. Schrock, Ching Ouyang, Jaideep Sandhu et al. · Annals of Oncology · 2019 · 628 citations

Medicine, Immunology, Oncology +17

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Wan‐Teck Lim, Boon Cher Goh, Edwin P. Hui et al. · Journal of Clinical Oncology · 2018 · 466 citations · Full text

Medicine, Oncology, Pharmacology +17

Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA

Jonathan E. Zuckerman, Ismael Gritli, Anthony W. Tolcher et al. · Proceedings of the National Academy of Sciences · 2014 · 410 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

NCCN Guidelines Insights: Antiemesis, Version 2.2017

Michael Berger, David S. Ettinger, J N Aston et al. · Journal of the National Comprehensive Cancer Network · 2017 · 248 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study

Thehang Luu, Robert J. Morgan, Lucille Leong et al. · Clinical Cancer Research · 2008 · 236 citations · Full text

Medicine, Oncology, Pharmacology +17